-
1
-
-
80051580618
-
Cancer statistics, 2011
-
doi:10.3322/caac.20121
-
Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011. CA A Cancer J Clin 61:212-236. doi:10.3322/caac.20121
-
(2011)
CA A Cancer J Clin
, vol.61
, pp. 212-236
-
-
Siegel, R.1
Ward, E.2
Brawley, O.3
Jemal, A.4
-
2
-
-
76049128595
-
Estimates of cancer incidence and mortality in Europe in 2008
-
doi:10.1016/j.ejca.2009.12.014
-
Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765-781. doi:10.1016/j.ejca.2009.12.014
-
(2010)
Eur J Cancer
, vol.46
, pp. 765-781
-
-
Ferlay, J.1
Parkin, D.M.2
Steliarova-Foucher, E.3
-
3
-
-
79956124273
-
Optimal management of metastatic colorectal cancer: Current status
-
doi: 10.2165/11591770-000000000-00000
-
McRee AJ, Goldberg RM (2011) Optimal management of metastatic colorectal cancer: current status. Drugs 71:869-884. doi: 10.2165/11591770-000000000-00000
-
(2011)
Drugs
, vol.71
, pp. 869-884
-
-
McRee, A.J.1
Goldberg, R.M.2
-
4
-
-
79961003508
-
Treatment of metastatic colorectal cancer
-
doi:10.1053/j.seminoncol.2011. 05.009
-
Davies JM, Goldberg RM (2011) Treatment of metastatic colorectal cancer. Semin Oncol 38:552-560. doi:10.1053/j.seminoncol.2011. 05.009
-
(2011)
Semin Oncol
, vol.38
, pp. 552-560
-
-
Davies, J.M.1
Goldberg, R.M.2
-
5
-
-
77956170550
-
New insights into apoptosis signaling by Apo2L/TRAIL
-
doi: 10.1038/onc.2010.221
-
Gonzalvez F, Ashkenazi A (2010) New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 29:4752-4765. doi: 10.1038/onc.2010.221
-
(2010)
Oncogene
, vol.29
, pp. 4752-4765
-
-
Gonzalvez, F.1
Ashkenazi, A.2
-
6
-
-
77956642345
-
Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: A promising approach to kill resistant cancer cells?
-
doi:10.1007/s00018-010-0407-6
-
Jacquemin G, Shirley S, Micheau O (2010) Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells? Cell Mol Life Sci 67:3115-3130. doi:10.1007/s00018-010-0407-6
-
(2010)
Cell Mol Life Sci
, vol.67
, pp. 3115-3130
-
-
Jacquemin, G.1
Shirley, S.2
Micheau, O.3
-
7
-
-
14644437742
-
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
-
DOI 10.1038/sj.cgt.7700792
-
Zhang L, Fang B (2005) Mechanisms of resistance to TRAILinduced apoptosis in cancer. Cancer Gene Ther 12:228-237. doi: 10.1038/sj.cgt.7700792 (Pubitemid 40315182)
-
(2005)
Cancer Gene Therapy
, vol.12
, Issue.3
, pp. 228-237
-
-
Zhang, L.1
Fang, B.2
-
8
-
-
77649190268
-
TRAILing death in cancer
-
doi:10.1016/j.mam.2009. 12.002
-
MellierG,Huang S, Shenoy K, Pervaiz S (2010) TRAILing death in cancer. Mol Aspects Med 31:93-112. doi:10.1016/j.mam.2009. 12.002
-
(2010)
Mol Aspects Med
, vol.31
, pp. 93-112
-
-
Mellierghuang, S.1
Shenoy, K.2
Pervaiz, S.3
-
9
-
-
67649122040
-
Differential induction of apoptosis by apple procyanidins in TRAIL-sensitive human colon tumor cells and derived TRAIL-resistant metastatic cells
-
Maldonado-Celis ME, Bousserouel S, Gossé F, Minker C, Lobstein A, Raul F (2009) Differential induction of apoptosis by apple procyanidins in TRAIL-sensitive human colon tumor cells and derived TRAIL-resistant metastatic cells. J Cancer Mol 5:21-30. http://www.mupnet.com/JOCM%205(1)%2021.htm
-
(2009)
J Cancer Mol
, vol.5
, pp. 21-30
-
-
Maldonado-Celis, M.E.1
Bousserouel, S.2
Gossé, F.3
Minker, C.4
Lobstein, A.5
Raul, F.6
-
10
-
-
70350336226
-
Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer
-
doi:10.1111/j.1476-5381.2009. 00266.x
-
Rushworth SA, Micheau O (2009) Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer. Br J Pharmacol 157:1186-1188. doi:10.1111/j.1476-5381.2009. 00266.x
-
(2009)
Br J Pharmacol
, vol.157
, pp. 1186-1188
-
-
Rushworth, S.A.1
Micheau, O.2
-
11
-
-
42749092258
-
TRAIL receptortargeted therapeutics: Resistance mechanisms and strategies to avoid them
-
doi:10.1016/j.drup. 2008.02.001
-
Thorburn A, Behbakht K, Ford H (2008) TRAIL receptortargeted therapeutics: resistance mechanisms and strategies to avoid them. Drug Resist Updat 11:17-24. doi:10.1016/j.drup. 2008.02.001
-
(2008)
Drug Resist Updat
, vol.11
, pp. 17-24
-
-
Thorburn, A.1
Behbakht, K.2
Ford, H.3
-
12
-
-
33847265733
-
Silybin and silymarin: New and emerging applications in medicine
-
Gazák R, Walterová D, Kren V (2007) Silybin and silymarin: new and emerging applications in medicine. Curr Med Chem 14:315-338
-
(2007)
Curr Med Chem
, vol.14
, pp. 315-338
-
-
Gazák, R.1
Walterová, D.2
Kren, V.3
-
13
-
-
84928068169
-
Toxicology and carcinogenesis studies of milk thistle extract (CAS No. 84604-20-6) in F344/N rats and B6C3F1 mice (Feed Studies)
-
(2011) Toxicology and carcinogenesis studies of milk thistle extract (CAS No. 84604-20-6) in F344/N rats and B6C3F1 mice (Feed Studies). Natl Toxicol Program Tech Rep Ser 1-177
-
(2011)
Natl Toxicol Program Tech Rep ser
, pp. 1-177
-
-
-
14
-
-
27644439523
-
Mechanisms and preclinical efficacy of silibinin in preventing skin cancer
-
DOI 10.1016/j.ejca.2005.03.033
-
SinghRP,AgarwalR (2005)Mechanisms and preclinical efficacy of silibinin in preventing skin cancer. Eur J Cancer 41:1969-1979. doi: 10.1016/j.ejca.2005. 03.033 (Pubitemid 41557682)
-
(2005)
European Journal of Cancer
, vol.41
, Issue.13
, pp. 1969-1979
-
-
Singh, R.P.1
Agarwal, R.2
-
15
-
-
33745002041
-
Prostate cancer chemoprevention by silibinin: Bench to bedside
-
DOI 10.1002/mc.20223
-
Singh RP, Agarwal R (2006) Prostate cancer chemoprevention by silibinin: bench to bedside. Mol Carcinog 45:436-442. doi: 10.1002/mc.20223 (Pubitemid 43865852)
-
(2006)
Molecular Carcinogenesis
, vol.45
, Issue.6
, pp. 436-442
-
-
Singh, R.P.1
Agarwal, R.2
-
16
-
-
62349117597
-
Growth inhibition and regression of lung tumors by silibinin: Modulation of angiogenesis by macrophageassociated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3
-
doi:10.1158/1940-6207.CAPR-08-0095
-
Tyagi A et al (2009) Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophageassociated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3. Cancer Prev Res (Phila) 2:74-83. doi:10.1158/1940-6207.CAPR-08-0095
-
(2009)
Cancer Prev Res (Phila)
, vol.2
, pp. 74-83
-
-
Tyagi, A.1
-
17
-
-
82955187812
-
Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells
-
doi:10.1007/s10495-011-0631-z
-
Kauntz H, Bousserouel S, Gossé F, Raul F (2011) Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells. Apoptosis 16:1042-1053. doi:10.1007/s10495-011-0631-z
-
(2011)
Apoptosis
, vol.16
, pp. 1042-1053
-
-
Kauntz, H.1
Bousserouel, S.2
Gossé, F.3
Raul, F.4
-
18
-
-
77957355392
-
Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules
-
doi:10.1007/s11095-010-0207-6
-
Velmurugan B et al (2010) Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules. Pharm Res 27:2085-2097. doi:10.1007/s11095-010-0207-6
-
(2010)
Pharm Res
, vol.27
, pp. 2085-2097
-
-
Velmurugan, B.1
-
19
-
-
62449168519
-
TRAIL agonists on clinical trials for cancer therapy: The promises and the challenges
-
Bellail AC, Qi L, Mulligan P, Chhabra V, Hao C (2009) TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. Rev Recent Clin Trials 4:34-41
-
(2009)
Rev Recent Clin Trials
, vol.4
, pp. 34-41
-
-
Bellail, A.C.1
Qi, L.2
Mulligan, P.3
Chhabra, V.4
Hao, C.5
-
20
-
-
33845899681
-
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients
-
DOI 10.1007/s10637-006-9019-2
-
Flaig TW et al (2007) A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Invest New Drugs 25:139-146. doi:10.1007/s10637-006-9019-2 (Pubitemid 46020872)
-
(2007)
Investigational New Drugs
, vol.25
, Issue.2
, pp. 139-146
-
-
Flaig, T.W.1
Gustafson, D.L.2
Su, L.-J.3
Zirrolli, J.A.4
Crighton, F.5
Harrison, G.S.6
Pierson, A.S.7
Agarwal, R.8
Glode, L.M.9
-
21
-
-
34548590339
-
Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin
-
DOI 10.1158/0008-5472.CAN-07-0407
-
Son Y-G et al (2007) Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and downregulation of c-FLIP and survivin. Cancer Res 67:8274-8284. doi:10.1158/0008-5472.CAN-07-0407 (Pubitemid 47395165)
-
(2007)
Cancer Research
, vol.67
, Issue.17
, pp. 8274-8284
-
-
Son, Y.-G.1
Eun, H.K.2
Jin, Y.K.3
Kim, S.U.4
Taeg, K.K.5
Yoon, A.-R.6
Yun, C.-O.7
Kyeong, S.C.8
-
22
-
-
0033664012
-
Validation of a model of colon cancer progression
-
doi:10.1002/1096-9896(2000) 9999:9999\:AID-PATH775[3.0.CO;2-K
-
Hewitt RE et al (2000) Validation of a model of colon cancer progression. J Pathol 192:446-454. doi:10.1002/1096-9896(2000) 9999:9999\:AID-PATH775[3.0. CO;2-K
-
(2000)
J Pathol
, vol.192
, pp. 446-454
-
-
Hewitt, R.E.1
-
23
-
-
0035710746
-
-deltadeltaC T method
-
DOI 10.1006/meth.2001.1262
-
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408. doi:10.1006/meth.2001.1262 (Pubitemid 34164012)
-
(2001)
Methods
, vol.25
, Issue.4
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
24
-
-
0032919099
-
Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique
-
DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2
-
Novo D, Perlmutter NG, Hunt RH, Shapiro HM (1999) Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique. Cytometry 35:55-63 (Pubitemid 29031192)
-
(1999)
Cytometry
, vol.35
, Issue.1
, pp. 55-63
-
-
Novo, D.1
Perlmutter, N.G.2
Hunt, R.H.3
Shapiro, H.M.4
-
25
-
-
22144458695
-
Fast neutrons-induced apoptosis is Fas-independent in lymphoblastoid cells
-
DOI 10.1016/j.bbrc.2005.06.125, PII S0006291X05013513
-
Fischer B et al (2005) Fast neutrons-induced apoptosis is Fasindependent in lymphoblastoid cells. Biochem Biophys Res Commun 334:533-542. doi:10.1016/j.bbrc.2005.06.125 (Pubitemid 40982399)
-
(2005)
Biochemical and Biophysical Research Communications
, vol.334
, Issue.2
, pp. 533-542
-
-
Fischer, B.1
Benzina, S.2
Jeannequin, P.3
Dufour, P.4
Bergerat, J.-P.5
Denis, J.-M.6
Gueulette, J.7
Bischoff, P.L.8
-
26
-
-
34347215518
-
Analysis of apoptosis by propidium iodide staining and flow cytometry
-
doi: 10.1038/nprot.2006.238
-
Riccardi C, Nicoletti I (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1:1458-1461. doi: 10.1038/nprot.2006.238
-
(2006)
Nat Protoc
, vol.1
, pp. 1458-1461
-
-
Riccardi, C.1
Nicoletti, I.2
-
27
-
-
79958186707
-
Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation
-
doi:10.1126/scitranslmed.3001384
-
Dolloff NG et al. (2011) Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation. Sci Transl Med 3:86ra50. doi:10.1126/scitranslmed.3001384
-
(2011)
Sci Transl Med
, vol.3
-
-
Dolloff, N.G.1
-
28
-
-
2342448582
-
Discovery of Embelin as a Cell-Permeable, Small-Molecular Weight Inhibitor of XIAP through Structure-Based Computational Screening of a Traditional Herbal Medicine Three-Dimensional Structure Database
-
DOI 10.1021/jm030420+
-
Nikolovska-Coleska Z et al (2004) Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem 47:2430-2440. doi:10.1021/jm030420? (Pubitemid 38580082)
-
(2004)
Journal of Medicinal Chemistry
, vol.47
, Issue.10
, pp. 2430-2440
-
-
Nikolovska-Coleska, Z.1
Xu, L.2
Hu, Z.3
Tomita, Y.4
Li, P.5
Roller, P.P.6
Wang, R.7
Fang, X.8
Guo, R.9
Zhang, M.10
Lippman, M.E.11
Yang, D.12
Wang, S.13
-
29
-
-
79952284127
-
Hallmarks of cancer: The next generation
-
doi:10.1016/j.cell.2011.02.013
-
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674. doi:10.1016/j.cell.2011.02.013
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
30
-
-
28544443984
-
Promoting apoptosis as a strategy for cancer drug discovery
-
DOI 10.1038/nrc1736
-
Fesik SW (2005) Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5:876-885. doi:10.1038/nrc1736 (Pubitemid 41746032)
-
(2005)
Nature Reviews Cancer
, vol.5
, Issue.11
, pp. 876-885
-
-
Fesik, S.W.1
-
31
-
-
77957965210
-
TRAIL: A sword for killing tumors
-
Wang S (2010) TRAIL: a sword for killing tumors. Curr Med Chem 17:3309-3317
-
(2010)
Curr Med Chem
, vol.17
, pp. 3309-3317
-
-
Wang, S.1
-
32
-
-
0035050960
-
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions [2]
-
DOI 10.1038/86397
-
Lawrence D et al (2001) Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med 7:383-385. doi: 10.1038/86397 (Pubitemid 32298514)
-
(2001)
Nature Medicine
, vol.7
, Issue.4
, pp. 383-384
-
-
Lawrence, D.1
Shahrokh, Z.2
Marsters, S.3
Achilles, K.4
Shih, D.5
Mounho, B.6
Hillan, K.7
Totpal, K.8
DeForge, L.9
Schow, P.10
Hooley, J.11
Sherwood, S.12
Pai, R.13
Leung, S.14
Khan, L.15
Gliniak, B.16
Bussiere, J.17
Smith, C.A.18
Strom, S.S.19
Kelley, S.20
Fox, J.A.21
Thomas, D.22
Ashkenazi, A.23
more..
-
33
-
-
0344827261
-
Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells
-
DOI 10.1038/sj.onc.1207158
-
Agarwal C et al (2003) Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22:8271-8282. doi:10.1038/sj.onc. 1207158 (Pubitemid 37485520)
-
(2003)
Oncogene
, vol.22
, Issue.51
, pp. 8271-8282
-
-
Agarwal, C.1
Singh, R.P.2
Dhanalakshmi, S.3
Tyagi, A.K.4
Tecklenburg, M.5
Sclafani, R.A.6
Agarwal, R.7
-
34
-
-
33646739493
-
Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: Silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences
-
doi:10.1158/ 1078-0432.CCR-05-2724
-
Hoh C et al (2006) Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences. Clin Cancer Res 12:2944-2950. doi:10.1158/ 1078-0432.CCR-05-2724
-
(2006)
Clin Cancer Res
, vol.12
, pp. 2944-2950
-
-
Hoh, C.1
-
35
-
-
59549107896
-
Silibinin inhibits hypoxiainducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: Implications for anticancer therapy
-
doi:10.1038/ onc.2008.398
-
Garc?́a-Maceira P, Mateo J (2009) Silibinin inhibits hypoxiainducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. Oncogene 28:313-324. doi:10.1038/ onc.2008.398
-
(2009)
Oncogene
, vol.28
, pp. 313-324
-
-
Garća-Maceira, P.1
Mateo, J.2
-
36
-
-
67349224064
-
Overexpression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP
-
doi:10.1016/j.canlet. 2009.01.035
-
Lee JT, Lee T-J, Kim C-H, Kim N-S, Kwon TK (2009) Overexpression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP. Cancer Lett 279:185-192. doi:10.1016/j.canlet. 2009.01.035
-
(2009)
Cancer Lett
, vol.279
, pp. 185-192
-
-
Lee, J.T.1
Lee, T.-J.2
Kim, C.-H.3
Kim, N.-S.4
Kwon, T.K.5
-
37
-
-
12544255082
-
Receptor-selective mutants of apoptosisinducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling
-
doi:10.1074/jbc.M410660200
-
Kelley RF et al (2005) Receptor-selective mutants of apoptosisinducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling. J Biol Chem 280:2205-2212. doi:10.1074/jbc.M410660200
-
(2005)
J Biol Chem
, vol.280
, pp. 2205-2212
-
-
Kelley, R.F.1
-
38
-
-
33646574281
-
The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand
-
DOI 10.1158/1535-7163.MCT-05-0431
-
Horinaka M et al (2006) The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosisinducing ligand. Mol Cancer Ther 5:945-951. doi:10.1158/ 1535-7163.MCT-05-0431 (Pubitemid 43724594)
-
(2006)
Molecular Cancer Therapeutics
, vol.5
, Issue.4
, pp. 945-951
-
-
Horinaka, M.1
Yoshida, T.2
Shiraishi, T.3
Nakata, S.4
Wakada, M.5
Sakai, T.6
-
39
-
-
20744456317
-
The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells
-
DOI 10.1016/j.bbrc.2005.05.179, PII S0006291X05012015
-
Horinaka M et al (2005) The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells. Biochem Biophys Res Commun 333:833-838. doi:10.1016/j.bbrc.2005. 05.179 (Pubitemid 40854234)
-
(2005)
Biochemical and Biophysical Research Communications
, vol.333
, Issue.3
, pp. 833-838
-
-
Horinaka, M.1
Yoshida, T.2
Shiraishi, T.3
Nakata, S.4
Wakada, M.5
Nakanishi, R.6
Nishino, H.7
Sakai, T.8
-
40
-
-
30444457090
-
Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells
-
DOI 10.1182/blood-2005-05-1982
-
HasegawaHet al (2006)DihydroflavonolBB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells. Blood 107:679-688. doi:10.1182/blood-2005-05-1982 (Pubitemid 43076394)
-
(2006)
Blood
, vol.107
, Issue.2
, pp. 679-688
-
-
Hasegawa, H.1
Yamada, Y.2
Komiyama, K.3
Hayashi, M.4
Ishibashi, M.5
Yoshida, T.6
Sakai, T.7
Koyano, T.8
Kam, T.-S.9
Murata, K.10
Sugahara, K.11
Tsuruda, K.12
Akamatsu, N.13
Tsukasaki, K.14
Masuda, M.15
Takasu, N.16
Kamihira, S.17
-
41
-
-
0033974084
-
Molecular determinants of response to TRAIL in killing of normal and cancer cells
-
Kim K, Fisher MJ, Xu SQ, el-Deiry WS (2000) Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin Cancer Res 6:335-346 (Pubitemid 30111448)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.2
, pp. 335-346
-
-
Kim, K.1
Fisher, M.J.2
Xu, S.-Q.3
El-Deiry, W.S.4
-
42
-
-
21244502158
-
Caspase-10 triggers bid cleavage and caspase cascade activation in fasL-induced apoptosis
-
DOI 10.1074/jbc.M414358200
-
Milhas D et al (2005) Caspase-10 triggers bid cleavage and caspase cascade activation in FasL-induced apoptosis. J Biol Chem 280:19836-19842. doi:10.1074/jbc.M414358200 (Pubitemid 41379510)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.20
, pp. 19836-19842
-
-
Milhas, D.1
Cuvillier, O.2
Therville, N.3
Clave, P.4
Thomsen, M.5
Levade, T.6
Benoist, H.7
Segui, B.8
-
43
-
-
33746886979
-
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
-
DOI 10.1038/sj.onc.1209608, PII 1209608
-
Fulda S, Debatin K-M (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25:4798-4811. doi:10.1038/sj.onc.1209608 (Pubitemid 44187627)
-
(2006)
Oncogene
, vol.25
, Issue.34
, pp. 4798-4811
-
-
Fulda, S.1
Debatin, K.-M.2
-
44
-
-
42049116091
-
Mcl-1: A gateway to TRAIL sensitization
-
DOI 10.1158/0008-5472.CAN-07-6278
-
Kim S-H, Ricci MS, El-Deiry WS (2008) Mcl-1: a gateway to TRAIL sensitization. Cancer Res 68:2062-2064. doi:10.1158/ 0008-5472.CAN-07-6278 (Pubitemid 351521775)
-
(2008)
Cancer Research
, vol.68
, Issue.7
, pp. 2062-2064
-
-
Kim, S.-H.1
Ricci, M.S.2
El-Deiry, W.S.3
-
45
-
-
7644231187
-
Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis
-
DOI 10.1038/sj.onc.1208069
-
Herrant M et al (2004) Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis. Oncogene 23:7863-7873. doi:10.1038/sj.onc.1208069 (Pubitemid 39457036)
-
(2004)
Oncogene
, vol.23
, Issue.47
, pp. 7863-7873
-
-
Herrant, M.1
Jacquel, A.2
Marchetti, S.3
Belhacene, N.4
Colosetti, P.5
Luciano, F.6
Auberger, P.7
-
47
-
-
2342615480
-
X-Linked Inhibitor of Apoptosis Protein (XIAP) Is a Nonredundant Modulator of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis in Human Cancer Cells
-
DOI 10.1158/0008-5472.CAN-04-0046
-
Cummins JM et al (2004) X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res 64:3006-3008 (Pubitemid 38581397)
-
(2004)
Cancer Research
, vol.64
, Issue.9
, pp. 3006-3008
-
-
Cummins, J.M.1
Kohli, M.2
Rago, C.3
Kinzler, K.W.4
Vogelstein, B.5
Bunz, F.6
-
48
-
-
53649109665
-
A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma
-
doi:10.1038/onc.2008.197
-
Ndozangue-Touriguine O et al (2008) A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma. Oncogene 27:6012-6022. doi:10.1038/onc.2008.197
-
(2008)
Oncogene
, vol.27
, pp. 6012-6022
-
-
Ndozangue-Touriguine, O.1
-
49
-
-
61349193762
-
Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells
-
doi:10.1038/ onc.2008.468
-
White-Gilbertson S et al (2009) Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene 28:1132-1141. doi:10.1038/ onc.2008.468
-
(2009)
Oncogene
, vol.28
, pp. 1132-1141
-
-
White-Gilbertson, S.1
-
50
-
-
34548662911
-
Effect of the XIAP inhibitor embelin on TRAIL-induced apoptosis of pancreatic cancer cells
-
DOI 10.1016/j.jss.2007.03.068, PII S0022480407001990
-
Mori T et al (2007) Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells. J Surg Res 142:281-286. doi:10.1016/j.jss.2007.03.068 (Pubitemid 47418828)
-
(2007)
Journal of Surgical Research
, vol.142
, Issue.2
, pp. 281-286
-
-
Mori, T.1
Doi, R.2
Kida, A.3
Nagai, K.4
Kami, K.5
Ito, D.6
Toyoda, E.7
Kawaguchi, Y.8
Uemoto, S.9
-
51
-
-
4143115887
-
Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis
-
DOI 10.1074/jbc.M405538200
-
Jin Z, McDonald ER, Dicker DT, El-Deiry WS (2004) Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J Biol Chem 279:35829-35839. doi:10.1074/jbc.M405538200 (Pubitemid 39100590)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.34
, pp. 35829-35839
-
-
Jin, Z.1
McDonald III, E.R.2
Dicker, D.T.3
El-Deiry, W.S.4
-
52
-
-
0029888514
-
Biological and clinical importance of the p53 tumor suppressor gene
-
Velculescu VE, El-Deiry WS (1996) Biological and clinical importance of the p53 tumor suppressor gene. Clin Chem 42:858-868
-
(1996)
Clin Chem
, vol.42
, pp. 858-868
-
-
Velculescu, V.E.1
El-Deiry, W.S.2
|